Felicity read Pharmacology at the University of Sunderland, where she also embarked on an industrial placement year at Bayer Pharmaceuticals in Slough. After completing her BSc (Hons), she moved to London to study for a Ph.D. in Pharmacology at Queen Mary University London, supported by the British Heart Foundation (BHF). Felicity was then awarded a BHF Junior Research Fellowship to undertake further research both in the UK and the USA.
In 2007 Felicity joined Imperial College London to take up a Lectureship position in the Centre for Integrative Mammalian Physiology and Pharmacology (CIMPP). This was shortly followed by a senior lectureship and the appointment to Deputy Head of The Centre of Neurodegeneration & Neuroinflammation. In 2013 she accepted an academic position in the USA at Louisiana State University Health Sciences Center-Shreveport (LSUHSC-S) and was appointed Director of The Small Animal Imaging Facility.
Felicity is a Fellow of the British Pharmacological Society and of the Royal Society of Biology. She joined Brunel University London in August 2019 as Professor of Pharmacology and Royal Society Wolfson Fellow, and is the Director of The Centre for Inflammation Research and Translational Medicine (CIRTM).
Throughout her academic career, Felicity has worked with and served on numerous national and international research councils, medical charities and learned societies. She has published widely in her field and received a number of awards and honours for her work. She has received funding for her research from a range of funders including: the Royal Society and the Wolfson Foundation (RSWF), the British Heart Foundation (BHF), the Medical Research Council (MRC), the Biotechnology and Biological Sciences Research Council (BBSRC), the American Heart Association (AHA), and the National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI).
Felicity continues to be actively involved in public and patient organizations which has been immensely instructive for her research. She is also dedicated to promoting mentoring and collaborative research, along with facilitating mentoring of post-doctoral fellows/early-career investigators.
- BSc (Hons)
- Director of The Centre for Inflammation Research and Translational Medicine (CIRTM). https://www.brunel.ac.uk/research/Centres/Inflammation-Research-and-Translational-Medicine
- Academy of Sciences Springboard champion for Brunel. https://acmedsci.ac.uk/grants-and-schemes/grant-schemes/springboard
- College Research Strategy Group (CRSG)
- University Animal Welfare Ethical Review Board (AWERB)
- Open Research Working Group
Newest selected publications
Boltersdorf, T., Gavins, FNE. and Long, NJ. (2021) 'Long-lived lanthanide emission via a pH-sensitive and switchable LRET complex'. Chemical Science, 12 (25). pp. 1 - 5. ISSN: 2041-6520 Open Access Link
Ansari, J. and Gavins, FNE. (2021) 'The Impact of Thrombo‐inflammation on the Cerebral Microcirculation'. Microcirculation, 28 (3). pp. e12689. ISSN: 1073-9688 Open Access Link
Ansari, J., Senchenkova, EY., Vital, SA., Al-Yafeai, Z., Kaur, G., Sparkenbaugh, E., (2021) 'Targeting AnxA1/Fpr2/ALX Regulates Neutrophil Function Promoting Thrombo-Inflammation Resolution in Sickle Cell Disease'. Blood, in press (11). pp. 1538 - 1549. ISSN: 0006-4971 Open Access Linket al.
Ansari, J., Vital, S., Esen, E. and Gavins, F. (2021) 'Targeting Peptidyl Arginine Deiminase 4 and NADPH Oxidase Pathways Regulates Neutrophil Dependent Thrombo-inflammation'.Pharmacology 2020.. ELECTR NETWORK. 1 - 18 December. WILEY. pp. 409 - 410. ISSN: 0007-1188
Vital, SA., Senchenkova, EY., Ansari, J. and Gavins, FNE. (2020) 'Targeting AnxA1/Formyl Peptide Receptor 2 Pathway Affords Protection against Pathological Thrombo-Inflammation'. Cells, 9 (11). pp. 1 - 18. ISSN: 2073-4409 Open Access Link